Search results
Results from the WOW.Com Content Network
1,3-Cyclohexanedione is an organic compound with the formula (CH 2) 4 (CO) 2. It is one of three isomeric cyclohexanediones . It is a colorless compound that occurs naturally.
Dimedone is an organic compound with the formula (CH 3) 2 C(CH 2) 2 (CO) 2 (CH 2). Classified as a cyclic diketone, it is a derivative of 1,3-cyclohexanedione. It is a white solid that is soluble in water, as well as ethanol and methanol. It once was used as a reagent to test for the aldehyde functional group.
In enzymology, a cyclohexane-1,3-dione hydrolase (EC 3.7.1.10) is an enzyme that catalyzes the chemical reaction. cyclohexane-1,3-dione + H 2 O 5-oxohexanoate. Thus, the two substrates of this enzyme are cyclohexane-1,3-dione and H 2 O, whereas its product is 5-oxohexanoate.
(3) A second C atom bonds to an H atom. The molecule leaves the surface. Hydrogenation is a chemical reaction between molecular hydrogen (H 2) and another compound or element, usually in the presence of a catalyst such as nickel, palladium or platinum. The process is commonly employed to reduce or saturate organic compounds.
Furthermore, this compound reacts with organocopper compounds from 1,4-addition (Michael addition), or with Grignard reagents 1,2-addition, i.e., with attack of the nucleophile at the carbonyl carbon atom. Cyclohexenone is also used in multi-step synthesis in the construction of polycyclic natural products.
The original Wieland–Miescher ketone is racemic and prepared in a Robinson annulation of 2-methyl-1,3-cyclohexanedione and methyl vinyl ketone. The intermediate alcohol is not isolated. An enantioselective synthesis employs L-proline as an organocatalyst: [7] This reaction was reported in 1971 by Z. G. Hajos and D. R. Parrish.
Cyclohexanedione may refer to: 1,2-Cyclohexanedione; 1,3-Cyclohexanedione; 1,4-Cyclohexanedione This page was last edited on 23 June 2017, at 01:22 (UTC). Text is ...
The mechanism of action of nitisinone involves inhibition of 4-Hydroxyphenylpyruvate dioxygenase (HPPD). [5] [6] This is a treatment for patients with Tyrosinemia type 1 as it prevents the formation of 4-Maleylacetoacetic acid and fumarylacetoacetic acid, which have the potential to be converted to succinyl acetone, a toxin that damages the liver and kidneys. [4]